364 related articles for article (PubMed ID: 16678831)
1. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study.
Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Can G
Atherosclerosis; 2007 Mar; 191(1):182-90. PubMed ID: 16678831
[TBL] [Abstract][Full Text] [Related]
2. Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective population-based study.
Onat A; Sari I; Hergenç G; Yazici M; Uyarel H; Can G; Sansoy V
Metabolism; 2007 Mar; 56(3):348-56. PubMed ID: 17292723
[TBL] [Abstract][Full Text] [Related]
3. Prospective epidemiologic evidence of a "protective" effect of smoking on metabolic syndrome and diabetes among Turkish women--without associated overall health benefit.
Onat A; Ozhan H; Esen AM; Albayrak S; Karabulut A; Can G; Hergenç G
Atherosclerosis; 2007 Aug; 193(2):380-8. PubMed ID: 16926017
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.
Onat A; Hergenç G; Uyarel H; Can G; Ozhan H
Anadolu Kardiyol Derg; 2006 Dec; 6(4):314-21. PubMed ID: 17162275
[TBL] [Abstract][Full Text] [Related]
5. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.
Onat A; Can G; Hergenç G
Metabolism; 2008 Feb; 57(2):207-14. PubMed ID: 18191050
[TBL] [Abstract][Full Text] [Related]
6. Serum uric acid is a determinant of metabolic syndrome in a population-based study.
Onat A; Uyarel H; Hergenç G; Karabulut A; Albayrak S; Sari I; Yazici M; Keleş I
Am J Hypertens; 2006 Oct; 19(10):1055-62. PubMed ID: 17027827
[TBL] [Abstract][Full Text] [Related]
7. [Prospective validation in identical Turkish cohort of two metabolic syndrome definitions for predicting cardiometabolic risk and selection of most appropriate definition].
Onat A; Hergenç G; Can G
Anadolu Kardiyol Derg; 2007 Mar; 7(1):29-34. PubMed ID: 17347072
[TBL] [Abstract][Full Text] [Related]
8. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
[TBL] [Abstract][Full Text] [Related]
9. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
[TBL] [Abstract][Full Text] [Related]
10. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
Misra KB; Endemann SW; Ayer M
Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of prehypertension for metabolic syndrome, diabetes, and coronary heart disease among Turks.
Onat A; Yazici M; Can G; Kaya Z; Bulur S; Hergenç G
Am J Hypertens; 2008 Aug; 21(8):890-5. PubMed ID: 18551102
[TBL] [Abstract][Full Text] [Related]
12. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
[TBL] [Abstract][Full Text] [Related]
13. Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels.
Onat A; Ozhan H; Erbilen E; Albayrak S; Küçükdurmaz Z; Can G; Keleş I; Hergenç G
Int J Cardiol; 2009 Jun; 135(2):211-7. PubMed ID: 18582961
[TBL] [Abstract][Full Text] [Related]
14. Measures of abdominal obesity assessed for visceral adiposity and relation to coronary risk.
Onat A; Avci GS; Barlan MM; Uyarel H; Uzunlar B; Sansoy V
Int J Obes Relat Metab Disord; 2004 Aug; 28(8):1018-25. PubMed ID: 15197408
[TBL] [Abstract][Full Text] [Related]
15. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.
Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S
Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378
[TBL] [Abstract][Full Text] [Related]
16. Obstructive sleep apnea syndrome is associated with metabolic syndrome rather than insulin resistance.
Onat A; Hergenç G; Uyarel H; Yazici M; Tuncer M; Doğan Y; Can G; Rasche K
Sleep Breath; 2007 Mar; 11(1):23-30. PubMed ID: 17061139
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional study of complement C3 as a coronary risk factor among men and women.
Onat A; Uzunlar B; Hergenç G; Yazici M; Sari I; Uyarel H; Can G; Sansoy V
Clin Sci (Lond); 2005 Feb; 108(2):129-35. PubMed ID: 15487975
[TBL] [Abstract][Full Text] [Related]
18. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance is associated with C-reactive protein independent of abdominal obesity in nondiabetic Taiwanese.
Chou HH; Hsu LA; Liu CJ; Teng MS; Wu S; Ko YL
Metabolism; 2010 Jun; 59(6):824-30. PubMed ID: 20004425
[TBL] [Abstract][Full Text] [Related]
20. C-reactive protein is elevated in obese patients with the metabolic syndrome.
Florez H; Castillo-Florez S; Mendez A; Casanova-Romero P; Larreal-Urdaneta C; Lee D; Goldberg R
Diabetes Res Clin Pract; 2006 Jan; 71(1):92-100. PubMed ID: 16002176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
